| Lopp Family Dental Pc | |
|
803 S Prairie St Brookston IN 47923-8410 | |
| (765) 563-6667 | |
| Not Available |
| Full Name | Lopp Family Dental Pc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 803 S Prairie St, Brookston, Indiana |
| Authorized Official Name and Position | Mackenzie Lopp (VICE PRESIDENT) |
| Authorized Official Contact | 7654144600 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Lopp Family Dental Pc Po Box 158 Brookston IN 47923-0158 Ph: (765) 563-6667 | Lopp Family Dental Pc 803 S Prairie St Brookston IN 47923-8410 Ph: (765) 563-6667 |
| NPI Number | 1417649682 |
|---|---|
| Provider Enumeration Date | 05/24/2023 |
| Last Update Date | 05/24/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417649682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
Why are some 75-year-olds downright spry while others can barely get around? Part of the explanation, say researchers writing in the Cell Press journal Trends in Molecular Medicine on May 28, is differences from one person to the next in exposure to harmful substances in the environment, chemicals such as benzene, cigarette smoke, and even stress.
A recent study at the University of Jyväskylä has found a surprisingly high level of mental well-being among middle-aged individuals.
A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria-the brain's cellular power plants-can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.
Researchers at Okayama University show how mechanical stress at very early stages of bone development alters expression pattern of the non-collagenous matrix responsible for biological property of the bone.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
› Verified 4 days ago